Trial Outcomes & Findings for Wound Infection Alexis Wound Retractor (NCT NCT00323453)

NCT ID: NCT00323453

Last Updated: 2018-11-23

Results Overview

Wound infections will be documents in both the traditional retraction arm and the wound protections device arm. The severity of appendicitis between the two groups will be matched.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

109 participants

Primary outcome timeframe

21 post operative days

Results posted on

2018-11-23

Participant Flow

Participant milestones

Participant milestones
Measure
Experimental Arm
The experimental arm will undergo open appendectomy utilizing the Alexis® retractor (wound protection device utilized intraoperatively), followed by standardized wound closure. Open appendectomy using Alexis Wound Retractor followed by standardized wound closure: The control arm subjects will undergo open appendectomy and standardized wound closure. The experimental arm will undergo open appendectomy utilizing the Alexis® retractor, followed by standardized wound closure.
Control Arm
Open appendectomy and standardized wound closure Open appendectomy with standardized wound closure: The control arm subjects will undergo open appendectomy and standardized wound closure. The experimental arm will undergo open appendectomy utilizing the Alexis® retractor, followed by standardized wound closure.
Overall Study
STARTED
61
48
Overall Study
COMPLETED
61
48
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Experimental Arm
n=61 Participants
The experimental arm will undergo open appendectomy utilizing the Alexis® retractor (wound protection device utilized intraoperatively), followed by standardized wound closure. Open appendectomy using Alexis Wound Retractor followed by standardized wound closure: The control arm subjects will undergo open appendectomy and standardized wound closure. The experimental arm will undergo open appendectomy utilizing the Alexis® retractor, followed by standardized wound closure.
Control Arm
n=48 Participants
Open appendectomy and standardized wound closure Open appendectomy with standardized wound closure: The control arm subjects will undergo open appendectomy and standardized wound closure. The experimental arm will undergo open appendectomy utilizing the Alexis® retractor, followed by standardized wound closure.
Total
n=109 Participants
Total of all reporting groups
Age, Continuous
35.4 years
STANDARD_DEVIATION 18.9 • n=61 Participants
33.1 years
STANDARD_DEVIATION 16.1 • n=48 Participants
34.4 years
STANDARD_DEVIATION 17.7 • n=109 Participants
Sex: Female, Male
Female
23 Participants
n=61 Participants
16 Participants
n=48 Participants
39 Participants
n=109 Participants
Sex: Female, Male
Male
38 Participants
n=61 Participants
32 Participants
n=48 Participants
70 Participants
n=109 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United States
61 participants
n=61 Participants
48 participants
n=48 Participants
109 participants
n=109 Participants
Number of Participants with physical barrier to protect the wound
61 Participants
n=61 Participants
48 Participants
n=48 Participants
109 Participants
n=109 Participants

PRIMARY outcome

Timeframe: 21 post operative days

Wound infections will be documents in both the traditional retraction arm and the wound protections device arm. The severity of appendicitis between the two groups will be matched.

Outcome measures

Outcome measures
Measure
Experimental Arm
n=61 Participants
The experimental arm will undergo open appendectomy utilizing the Alexis® retractor (wound protection device utilized intraoperatively), followed by standardized wound closure. Open appendectomy using Alexis Wound Retractor followed by standardized wound closure: The control arm subjects will undergo open appendectomy and standardized wound closure. The experimental arm will undergo open appendectomy utilizing the Alexis® retractor, followed by standardized wound closure.
Control Arm
n=48 Participants
Open appendectomy and standardized wound closure Open appendectomy with standardized wound closure: The control arm subjects will undergo open appendectomy and standardized wound closure. The experimental arm will undergo open appendectomy utilizing the Alexis® retractor, followed by standardized wound closure.
Post-operative Wound Infection, After Open Appendectomy
1 Participants
7 Participants

Adverse Events

Experimental Arm

Serious events: 1 serious events
Other events: 0 other events
Deaths: 0 deaths

Control Arm

Serious events: 7 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Experimental Arm
n=61 participants at risk
The experimental arm will undergo open appendectomy utilizing the Alexis® retractor (wound protection device utilized intraoperatively), followed by standardized wound closure. Open appendectomy using Alexis Wound Retractor followed by standardized wound closure: The control arm subjects will undergo open appendectomy and standardized wound closure. The experimental arm will undergo open appendectomy utilizing the Alexis® retractor, followed by standardized wound closure.
Control Arm
n=48 participants at risk
Open appendectomy and standardized wound closure Open appendectomy with standardized wound closure: The control arm subjects will undergo open appendectomy and standardized wound closure. The experimental arm will undergo open appendectomy utilizing the Alexis® retractor, followed by standardized wound closure.
Skin and subcutaneous tissue disorders
Wound Infection
1.6%
1/61 • Number of events 1
14.6%
7/48 • Number of events 7

Other adverse events

Adverse event data not reported

Additional Information

Laura Isaacs (Research Quality Assurance & Integrity Analyst) on behalf of Dr. Kenneth Waxman (PI)

Santa Barbara Cottage Hospital

Phone: 805-324-9255

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place